Medicine
fromwww.theguardian.com
4 days agoImmunotherapy could be used to treat depression, early trial suggests
Tocilizumab may improve difficult-to-treat depression symptoms in patients unresponsive to standard antidepressants by blocking IL-6R–mediated inflammatory signaling.